InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
-8.4%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Ekman Lars, Director. Officer active across 2 companies, notably Ultragenyx Pharmaceutical Inc.. Aggregated, 8 reports have been logged. Activity tracked since 24 June 2021. The latest transaction was disclosed on 3 January 2023 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
15,834 shares@ US$6.4115.7% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-23-000574:0
15,834 shares@ US$6.4116.0% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-22-044319:0
15,833 shares@ US$6.4116.9% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-22-039911:0
15,833 shares@ US$6.4117.0% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-22-018291:0
31,666 shares@ US$6.4134.4% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-22-035561:0
3,300 shares0Common StockSEC:0001209191-22-039567:0
2,145 shares0Common StockSEC:0001209191-21-043543
2,145 shares0Common StockSEC:0001209191-21-043543:0
8 of 8 declarations
About Ekman Lars
Lars Ekman is a Board Member at Ultragenyx Pharmaceutical Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and guiding research and development initiatives. With expertise in the pharmaceutical sector, Lars is well-positioned to provide valuable insights to the management team. His commitment to innovation and improving healthcare is essential for Ultragenyx.
